On December 22, 2022 the U.S. Food and Drug Administration (FDA) announced the Class I recall of reworked Philips Respironics Trilogy 100 and Trilogy 200 ventilators. A Class I recall is the FDA’s most serious recall, indicating devices create a heightened risk of serious injury or death. Trilogy ventilators are intended to … [Read more...] about FDA Recalls Reworked Philips Respirators